Health news
Gilead Sciences has announced the removal of counterfeit and tampered Gilead-labeled HIV medications, including bottles labeled as Biktarvy® (bictegravir, emtricitabine, tenofovir alafenamide) and Descovy® (emtricitabine and tenofovir alafenamide), from the US supply chain. Biktarvy is…
A multicomponent diagnostic strategy was found to increase the number of patients being tested, diagnosed, and treated for confirmed tuberculosis (TB) infection, according to results of a cluster-randomized study published in The New England Journal…
The Food and Drug Administration (FDA) has approved Apretude (cabotegravir extended-release injectable suspension) for use in at-risk adults and adolescents weighing at least 35kg for preexposure prophylaxis (PrEP) to reduce the risk of sexually acquired…
The Food and Drug Administration (FDA) has placed clinical holds on studies evaluating islatravir (MK-8591), an investigational nucleoside reverse transcription translocation inhibitor, for the treatment and prevention of HIV-1 infection. The clinical holds were based…
Although there were few differences overall in vaginal cytokine and microbiota profiles before and after condomless vaginal intercourse between women who use lubricants vs those who do not, women who used lubricants were found to…
Vertical transmission of HIV infection during the peripartum period or while breastfeeding was associated with maternal HIV drug resistance, viral load, and CD4 counts These findings, from a case-control study, were published in Clinical Infectious…
The Food and Drug Administration has accepted for Priority Review the New Drug Application for long-acting cabotegravir injection for HIV pre-exposure prophylaxis (PrEP). The application is supported by data from the phase 2b/3 HPTN 083…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021